0%
0%
0%
0%
0%
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
See all ideas
Tilray turns green after fitting a surprise profit and an exciting new hemp deal into one well-rolled earnings report.
Investors get the munchies for pot stocks on Thursday after the House brings up the potential of decriminalization.
You’re not ganja believe this, but Tilray turned a surprise profit in FQ2.
Chuck Schumer throws cold water on pot stocks’ recent highs with a new argument against legalization.
The U.S. is so keen for federal legalization that Republicans and Democrats have started to work together, with the marijuana industry loudly cheering them on.
A leaked Republican legalization bill gets cannabis stocks blazing on Monday.
Cannabis stocks take a hit (the good kind) after positive news from Philly.
Tilray investors are feeling high on life after cannabis giant Tilray is chosen as the supplier for Luxembourg's Medical Cannabis Program, sending shares up just under 2%.
Tilray is smoking hot, up over 15% after the cannabis company appoints a new President for Tilray Canada.
Tilray CEO Irwin Simon has been given a whopping $13.2 million in cash bonuses this year, enough to make anyone feel sky high.
Pot stocks are smoking hot at the moment as the increasingly real prospect of U.S. legalization rears its head once more, sending Tilray soaring over 4%.
See all events